31 August - 04 September 2019, Paris - France

Session Details

I.V. Inodilators: why, when and how?
Mon 02 Sep 13:00 - 13:45 Acute Heart Failure Satellite Symposium Duras - The Hub
Chairpersons: John T PARISSIS (Athens, Greece), Francesco FEDELE (Roma, Italy)
Subtitle: Sponsored by Orion Pharma
Learning Objectives: - The use of inotropes for correcting hemodynamic dysfunction and relieving symptoms in patients with congestive heart failure is debated. - Negative or insufficient data has been collected on the effects of cardiac glycosides, cathecolamines and phosphodiesthrase inhibitors on quality of life and survival. - Drugs which are both calcium sensitizers and potassium channels openers have been proposed as safer inodilators in acute and advanced heart failure.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
13:003882Inodilators in acute heart failure/cardiogenic shockFinn GUSTAFSSON (Copenhagen, Denmark), Veli-Pekka HARJOLA (Helsinki, Finland)
13:143883Inodilators in advanced heart failure Gerhard POLZL (Innsbruck, Austria), Josep COMIN-COLET (Hospitalet De Llobregat, Spain)
13:283884Inodilators and cardio-renal syndromePiergiuseppe AGOSTONI (Milan, Italy), Carsten TSCHOEPE (Berlin, Germany)
13:423885Take home message: I.V. Inodilators: why, when and howJohn T PARISSIS (Athens, Greece)